Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terconazole vs Fluconazole for Severe Vulvovaginal Candidiasis
NCT02180100Phase 4Completed
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Aug 2013
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of terconazole in vulvovaginal candidiasis (VVC), sponsored by Peking University Shenzhen Hospital. Started Aug 2013; status: completed.
02
Drugs
terconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02180100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180100.